Universal flu vaccine heads for clinical trials

Israel’s BiondVax has received FDA approval of its application to proceed with clinical trials of its universal Multimeric-001 flu vaccine (M-001).


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *